GALNS rs199638097: What Your Genotype Means
The rs199638097 variant is a specific genetic change located within the GALNS gene. It is recognized in clinical databases as a potential carrier marker for Mucopolysaccharidosis type IV-A, a rare lysosomal storage disorder.
What each genotype means
Typical genetic profile
This genotype represents the most common sequence found at this position in the GALNS gene. It is not associated with the carrier status for Mucopolysaccharidosis type IV-A.
This is the most common genotype observed across all global populations.
Mucopolysaccharidosis IV-A carrier
This genotype indicates you carry one copy of the variant associated with Mucopolysaccharidosis type IV-A, a lysosomal storage disorder. As this is a recessive condition, carriers typically do not exhibit symptoms of the disorder, but you should consult with a genetic counselor to understand the implications for family planning.
This genotype is rare and observed at a very low frequency in the general population.
Potential clinical significance
This genotype indicates the presence of two copies of the variant. Because this variant is linked to Mucopolysaccharidosis type IV-A, individuals with this result should discuss the findings with a medical professional or clinical geneticist to determine if further diagnostic testing or clinical evaluation is appropriate.
This genotype is extremely rare in the general population.
Understanding the Variant and Its Location
The variant rs199638097 is a single nucleotide polymorphism (SNP) situated on chromosome 16 at position 88,842,811 (GRCh38). In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located within the GALNS gene, which provides the blueprint for the N-acetylgalactosamine-6-sulfatase enzyme. Because this gene is located on chromosome 16, it is inherited in an autosomal manner, meaning both males and females carry two copies of the gene—one inherited from each parent. Variations in this region are of interest to researchers because they can alter the structure or function of the resulting protein, potentially impacting how the body processes complex sugar molecules known as glycosaminoglycans.
The Role of the GALNS Gene
The GALNS gene is essential for the proper function of lysosomes, which are the recycling centers of the cell. The enzyme produced by this gene, N-acetylgalactosamine-6-sulfatase, is responsible for breaking down specific glycosaminoglycans (GAGs), particularly keratan sulfate and chondroitin-6-sulfate. When the GALNS gene contains pathogenic mutations that significantly reduce or eliminate enzyme activity, these GAGs cannot be broken down efficiently. Over time, this leads to their accumulation within lysosomes, which can interfere with normal cellular processes and contribute to the development of Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome. This condition is characterized by skeletal abnormalities and other systemic health issues resulting from the progressive buildup of these undegraded molecules in various tissues throughout the body.
Research Associations and Evidence Strength
The association between variants in the GALNS gene and Mucopolysaccharidosis type IV-A is well-established in medical literature. While many different mutations in this gene have been identified, the clinical significance of any single variant, such as rs199638097, depends on the specific evidence linking it to reduced enzymatic function. Current research classifies this variant as a carrier marker, meaning that individuals who carry one copy of a pathogenic variant may not exhibit symptoms of the disorder themselves, as they typically have a second, functional copy of the gene. However, if both parents are carriers of pathogenic variants in the same gene, there is a risk of passing the condition to their children. The evidence strength for specific rare variants can be limited, and clinical interpretation often requires comprehensive genetic counseling to understand the implications for family planning.
Population Frequency and Interpretation
The rs199638097 variant is considered rare in the general population. Genetic databases like gnomAD provide insights into how frequently specific alleles appear across different ancestral groups. Because this variant is rare, it is not commonly found in the general public, and its presence is often investigated in the context of clinical diagnostic testing for individuals with a family history of lysosomal storage disorders. It is important to note that the presence of a rare variant does not automatically imply a health risk. Genetic testing results should always be interpreted by a qualified healthcare professional or a genetic counselor who can place the finding in the context of an individual's personal and family medical history.
What You Can and Cannot Do With This Information
Information regarding your carrier status for a rare genetic variant is a tool for personal knowledge and family health planning. If you have received results indicating you are a carrier for a GALNS variant, you cannot use this information to diagnose yourself or others with a medical condition. Carrier status generally does not cause symptoms. Instead, this information is most useful when shared with a physician or a genetic counselor, especially if you are planning a family. They can help you understand the inheritance patterns of autosomal recessive conditions and discuss the possibility of partner testing. Never make medical decisions based solely on raw genetic data; always consult with a clinician who can provide professional guidance based on your full clinical picture.
How common is this variant?
The rs199638097 variant is rare across global populations, with specific frequency data varying by ancestry in large-scale genomic databases.
Frequently asked questions
What is Mucopolysaccharidosis type IV-A?
Mucopolysaccharidosis type IV-A, or Morquio A syndrome, is a rare genetic disorder caused by a deficiency in the GALNS enzyme. This deficiency leads to the accumulation of glycosaminoglycans in the body, which can cause skeletal abnormalities and other health complications.
Does being a carrier mean I have the disease?
Generally, being a carrier for an autosomal recessive condition like Mucopolysaccharidosis type IV-A means you have one copy of a variant but do not have the disease. Carriers typically do not show symptoms because they have a second, functional copy of the gene.
Should I be worried if I have the C/T genotype?
Finding a carrier variant is common, as most people carry several rare variants. You should discuss this result with a genetic counselor or your doctor to understand what it means for your health and family planning.
Is there a cure for Mucopolysaccharidosis type IV-A?
There is no cure for the underlying genetic cause of the disorder, but treatments such as enzyme replacement therapy are available to help manage symptoms. These therapies are designed to replace the missing enzyme activity in the body.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs199638097?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GALNS
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A (Morquio syndrome).
This variant is a pathogenic mutation linked to carrier status for Mucopolysaccharidosis type IV-A.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A.
This variant is associated with carrier status for Mucopolysaccharidosis type IV-A (MPS-IV-A).